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Abstract
Rodwan, Naima. M.S., Department of Pharmacology and Toxicology, Wright State University, 2012.

Light-Limited Access to Fructose Alters Metabolic Function and Adipose Tissue
Catecholaminergic Activity in Mice

Consumption of high levels of fructose produces glucose intolerance, sympathetic nervous
system activation, and renal dysfunction. A diet high in fructose may play a role in the
worldwide epidemic of obesity and diabetes. The aim of this study was to test the hypothesis
that time (light/dark) limited access to fructose influences body fat, metabolic function, and
adipose tissue catecholaminergic activity in mice. Male C57BL/6 mice were given standard
chow and assigned to one of three groups: Control (n=10, water 24h); FL (n=11, 10% fructose
solution during 12h light period); and FD (n=10, 10% fructose solution during 12h dark
period). Metabolic parameters measured were body fat (BF, Echo-MRI), adipocyte cell size, and
glucose tolerance as well as plasma glucose, adiponectin, insulin, leptin, triglycerides, and
cholesterol. Catecholamine levels were measured directly in white adipose tissue (WAT) using
high

performance

liquid

chromatography

(HPLC)

with

electrochemical

detection.

Immunochemistry was used for examining tyrosine hydroxylase (TH) staining in WAT
and brainstem. Mice given fructose during the light phase (inactive period for mice) showed
evidence for a diabetic like symptoms with prominent changes in adipose tissue fat. Results
showed: 1) enhanced increase in BF and increased size of adipocytes in FL; 2) increased plasma
insulin and leptin in FL without changes in glucose or glucose tolerance; 3) no change in
cholesterol or triglycerides; 4) measurable amounts of norepinephrine (NE), epinephrine (EPI) in
WAT without difference among groups; 5) enhanced staining for TH in WAT and brainstem
locus coeruleus. The changes in adiposity occurred even though caloric intake was not different
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among groups. In conclusion, results document that restriction of fructose access to the light
period produced pathological effects on metabolic function along with catecholaminergic
activation in WAT and brainstem. These data may have clinical implications since the timing of
intake may be important in the control of adiposity and the development of metabolic syndrome.
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1. INTRODUCTION
1.1 Adipose tissue overview

Figure 1: H & E staining in WAT from an obese mouse.
Fat cells are approximately twice as large as controls.

White adipose tissue (WAT) forms the largest fat depot in the body, localized primarily in the
abdomen and the subcutaneous layer. The fat is stored in adipocytes which form a mesh-like
cellular network (Figure 1). The cells act as storage vessels for triglyceride (TG) which is
metabolized to release free fatty acids (FFAs) into the circulation. FFAs in turn provide energy
for bodily functions. WAT also contains preadipocytes, fibroblasts, mast cells, mesenchymal
cells, endothelial cells, and stromovascular cells (Frayn, Karpe, Fielding, Macdonald, &
Coppack, 2003). WAT is considered to be an endocrine organ because it produces the metabolic
hormones, leptin, adiponectin, and resistin as well as the immunological modulators, IL-6 and
TNF-α.
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1.2. Leptin
Leptin is a 167-amino acid peptide (Brennan & Mantzoros, 2006; Zhang et al., 1997) produced
almost exclusively in adipose tissue (Margetic, Gazzola, Pegg, & Hill, 2002). Its secretion is
influenced by fat mass and changes in energy status (Considine et al., 1996). A reduction of
leptin either in humans or rodents leads to increased body weight (BW) and body fat (BF).
Leptin is particularly important in the obesity syndrome because it regulates food intake and
energy expenditure (Zhang et al., 1994). Leptin binds to leptin receptors (ObRbs) located
throughout the central nervous system (CNS) and peripheral tissues (Fei et al., 1997). The ObRb
receptor is highly expressed in the hypothalamus, which is involved in energy homeostasis
(Elmquist, Bjorbaek, Ahima, Flier, & Saper, 1998; Fei et al., 1997). After release from
adipocytes, leptin is transported though the blood-brain barrier into the CNS, where it causes
hunger inhibition and a sensation of satiety. Insulin and leptin, act together as peripheral signals
to the CNS, regulating feeding behavior and metabolic homeostasis (Niswender & Schwartz,
2003). The nocturnal rise in leptin secretion is entrained to mealtime probably responding to the
cumulative hyperinsulinemia which stimulates leptin secretion from adipose tissue (Sinha &
Caro, 1998). Change or deletion in leptin receptors has the opposite effects, obesity and diabetes.
An example of a pathological genetic model is the db/db mouse which has a mutation of the Ob
receptor (White & Tartaglia, 1996). A mutation in a human gene in similar manner produced
obesity and glucose intolerance, (Licinio et al., 2004)
1.3. Leptin and insulin
Leptin has peripheral effects on insulin secretion and insulin action which leads to changes in
metabolism of adipocytes, skeletal muscle, and other tissues. Leptin is considered to be an
important regulator of peripheral glucose homeostasis. Like leptin, insulin also has receptors in

2

the hypothalamus with secretion proportional to fat stores (Baskin, Wilcox, Figlewicz, & Dorsa,
1988). Experimental studies have shown that prolonged intravenous leptin infusion increases
glucose use and increases tissue sensitivity to insulin. Insulin plays an important role in the
regulation of leptin secretion and vice versa for leptin and insulin secretion. It is thought that
insulin increases leptin production by adipose tissue, whereas, leptin inhibits insulin secretion
and insulin gene expression. The suppressive action of leptin on insulin production is regulated
both by the autonomic nervous system and directly by influence on leptin receptors in B cells in
pancreas.
1.4. Leptin and the sympathetic (SNS) nervous system
The interrelationship between leptin and the SNS is very strong. Leptin stimulates the SNS,
seen by increased blood pressure (BP), thermogenesis (Scarpace, Matheny, Pollock, & Tumer,
1997), and increased NE turnover (Collins et al., 1996). Leptin infusion also increases renal
sympathetic nerve activity (SNA) by increasing sympathetic outflow to the kidney (Haynes,
Morgan, Walsh, Mark, & Sivitz, 1997). The sympathetic stimulatory effects were absent in
Zucker rats (fa/fa) that have mutations in leptin receptors (Haynes et al., 1997). Likewise in
ob/ob mice, leptin produced no increase in NE turnover in WAT, an effect produced by leptin
resistance. The proposed scenario is that leptin which is released from adipose tissue activates
the SNS (Haynes et al., 1997) with inhibition of leptin secretion by SNS activation as a feedback
mechanism (Hardie, Rayner, Holmes, & Trayhurn, 1996; Ricci, Fried, & Mittleman, 2000).
Experimental studies in rats and mice showed increase in leptin mRNA and in plasma leptin after
blockade of NE synthesis (Rayner & Trayhurn, 2001; Sivitz et al., 1999). Data indicate a role of
SNS in leptin gene expression modulation through a feedback loop to adipose tissue.
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1.5. Sympathetic neural innervation of white adipose tissue
One of the first studies to show direct WAT innervation by the SNS (postganglionic SNS fibers)
was performed in hamsters (Youngstrom & Bartness, 1995). Using histofluorescence,
catecholaminergic fibers could easily be visualized in WAT (Rebuffe-Scrive, 1991; Slavin &
Ballard, 1978). Immunostaining for tyrosine hydroxylase (TH), a specific marker of sympathetic
noradrenergic nerves, (Wilson et al., 1988) (Flatmark, 2000) also provided evidence for
adrenergic innervation of WAT.

The pathway for innervation was documented using

pseudorabies virus for track tracing (Bamshad, Aoki, Adkison, Warren, & Bartness, 1998). SNS
outflow from the brain to different depots of WAT is well documented (Bamshad et al., 1998;
Bowers et al., 2004). After injection of pseudorabies (a transport marker) in WAT, there was
widespread labeling in brainstem regions which control food intake and contain leptin receptors
(Mercer, Moar, & Hoggard, 1998). In the hypothalamus, there was viral infection in the
paraventricular nucleus (PVN), a region involved in sympathetic responses including blood
pressure elevation and induction of lipolysis (Bartness & Bamshad, 1998). There was little
labeling in the ventromedial hypothalamus even though this region is also involved in
sympathetic responses and appetite control. TG storage is known as lipogenesis while secretion
is known as lipolysis. High levels of lipogenesis cause obesity which is associated with
hypertension, insulin resistance, and inflammation (Gustafson et al., 2009). WAT is heavily
innervated by sympathetic fibers emanating from the CNS. The sympathetic terminals are
involved in the control of fat secretion via activation of β-adrenergic receptors. In addition to
adrenergic input, pancreatic insulin has prominent actions in WAT including inhibition of
lipolysis (Chakrabarti & Kandror, 2011).
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1.6. Energy balance in white adipose tissue
The action of the SNS in WAT is mediated by β-adrenoceptors (β-AR) and α2-adrenoceptors
(α2-AR) (Lafontan et al., 1995). Catecholamines, NE and EPI, are released from the adrenal
medulla or sympathetic nerve terminals and stimulate lipolysis by activating β receptors (Chu,
Huddleston, Clancy, Harris, & Bartness, 2010; Carpene, Bousquet-Melou, Galitzky, Berlan, &
Lafontan, 1998; Nonogaki, 2000; Bartness & Bamshad, 1998). Catecholamines also exert
antilipolytic effects through stimulation of α2-AR. EPI and NE have a higher affinity for α2-AR
than for β-AR indicating a role for the α2 adrenergic pathway in the control of lipolysis (Chen et
al., 1996). If the activation of β-AR in WAT is stronger than the α-AR, then lipolysis is
activated. If α-AR predominate, then lipolysis is inhibited (Bartness & Bamshad, 1998). Insulin
has an inhibitory effect on lipolysis by reducing the number of adrenergic binding sites available
by translocation of insulin receptors to the intracellular compartments. This causes a
desensitization of ARs to catecholamine-stimulated lipolysis (Engfeldt, Hellmer, Wahrenberg, &
Arner, 1988).
1.7. Pathophysiological effects of fructose
Fructose is found naturally in a variety of foods, such as fruits, honey, and vegetables. Fructose
has a chemical formula C H O

similar to glucose. In glucose, an aldehyde group is attached

at carbon 1, while in fructose the keto group is attached to carbon 2. The specificity and time
course of fructose metabolism in the liver is related to the high maximum velocity of an enzymatic
reaction (Vm) and low dissociation constant of the enzyme-substrate complex (Km) of fructokinase

(Heinz, Lamprecht, & Kirsch, 1968; Adelman, Ballard, & Weinhouse, 1967). In contrast to
glucose, hepatic metabolism of fructose is not regulated by insulin. In the first step of fructose
metabolism in the liver, phosphorylation of fructose to fructose -1 phosphate occurs rapidly by
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the action of fructokinase enzyme. This step occurs independently of insulin and without ATP
feedback (Bruynseels et al., 1999; Cortez-Pinto et al., 1999). The rapid phosphorylation of
fructose in the liver produces substrates for gluconeogenesis and lipogenesis.
The dramatic increase in fructose consumption in the last decades is thought to bear a
relationship with the increased incidence of metabolic syndrome. In 2007, fructose intake in
adults averaged almost 65 gm/day, mainly in the form of high fructose corn syrup (HFCS)
(Tappy & Le, 2010). This global increase in fructose consumption is correlated with increased
prevalence of metabolic syndrome, and type 2 diabetes mellitus (Montonen, Jarvinen, Knekt,
Heliovaara, & Reunanen, 2007; Palmer et al., 2008), and obesity (Lustig, 2006; Isganaitis &
Lustig, 2005). These syndromes are also associated with hypertension and cardiovascular disease
(Dhingra et al., 2007; Fung et al., 2009).
1.8. Effect of fructose on the sympathetic nervous system
The activating effect of dietary carbohydrates on SNS activity was originally documented more
than 25 years ago (Young & Landsberg, 1977). Results showed that high fructose consumption
produces hypertension and insulin resistance in rodents (Dai & McNeill, 1995). One of the
possible mechanisms was via increases in sympathetic neural outflow which increases plasma
insulin and blood pressure (Hwang, Ho, Hoffman, & Reaven, 1987; Reaven, 1993). It was
demonstrated in humans that fructose infusion amplified the release of EPI (Gabriely, Hawkins,
Vilcu, Rossetti, & Shamoon, 2002). The ingestion of fructose in rats increased plasma and
urinary NE

(Jansen, Penterman, van Lier, & Hoefnagels, 1987) and increased adrenergic

receptor expression in the heart (Kamide et al., 2002). Moreover, fructose feeding in mice
produced nocturnal hypertension, sympathetic activation, and CNS catecholaminergic changes
(Farah et al., 2006).
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1.9. Circadian rhythms and fructose consumption
Circadian rhythms should also be considered in the etiology of metabolic and cardiovascular
pathologies associated with diabetes. Organisms adapt to their changing environment through
tapping into a central clock, i.e., the suprachiasmatic nucleus (SCN). There are also independent
peripheral clocks located in organs such as the liver and fat. Moreover, alterations in the pattern
of eating, activity and sleeping may play a role in the development of metabolic syndrome (body
weight, blood pressure, and insulin resistance). In humans, this is seen in pathologies associated
with shift work, such as diabetes, weight gain, hypertension, coronary artery disease and other
maladies (Morikawa et al., 2005; Esquirol et al., 2009). Even a short term alteration in day/night
rhythms, such as from jet lag, was sufficient to produce an increase in blood pressure as well as
metabolic derangements (Scheer, Hilton, Mantzoros, & Shea, 2009). In animals or humans,
alteration of the feeding schedule resulted in significant changes in metabolic and endocrine
parameters (Arble, Bass, Laposky, Vitaterna, & Turek, 2009; Kudo et al., 2004; Bodosi et al.,
2004; Zvonic et al., 2006; Colles, Dixon, & O'Brien, 2007). People with “night time eating”
syndrome have a total caloric intake which is not different from healthy subjects. However,
people with this syndrome gain more weight and have depression (Allison et al., 2005; Colles et
al., 2007). Experimentally, feeding a group of mice a high fat diet in the inactive time (light
period) also gave similar results, that is, greater weight gain without differences in caloric intake
or activity (Arble et al., 2009). Similarly, changing the light cycle by exposing the animal to low
light during the dark time, resulted in a syndrome of obesity and insulin resistance (Fonken et al.,
2010). When animals were forced to eat during the light, leptin levels were also increased
(Bodosi et al., 2004).
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1.10. Summary
Alterations in the pattern of eating, activity, and sleeping may play a role in the development of
the metabolic syndrome (increased body weight, blood pressure, and development of insulin
resistance). In humans, this is seen in pathologies associated with shift work, such as, diabetes,
obesity, hypertension, and coronary artery disease. Moreover, reversal of day/night cycles has
effects on organs such as adipose tissue through the production of leptin and adiponectin. In
addition to the function of adipose tissue as a reservoir for fat and an energy source, it is
considered to be the body’s largest endocrine organ. In view of previous experiments which
demonstrated that the day/night pattern of intake of sugar influences the development of
metabolic pathologies, a protocol was designed in which the risk of both was combined. It was
hypothesized that fructose provided in the light sleeping period in mice would exacerbate the
sympathetic neural and metabolic responses. Consumption of fructose may result in obesity,
diabetes, and autonomic dysfunction. Recently, studies have shown that the consumption of
fructose enhances the diabetic state by causing elevation in insulin levels. The rise in obesity
with fructose consumption may occur because of its role in the lipogenic process. Increasing
adiposity and metabolic disturbances are also seen following alterations in day/night feeding
schedule. The aim of this study combined the effect of fructose and alteration of day time to test
whether light-limited access to fructose alters metabolic function and adipose tissue
catecholaminergic activity in mice.
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2. HYPOTHESIS AND SPECIFIC AIMS
2.1. Hypothesis
The timing of the access to dietary fructose intake will influence the metabolic and
catecholaminergic response to fructose consumption. The hypothesis predicts that fructose given
in light period in mice will increase catecholamine use in adipose tissue and catecholaminergic
activity in the brainstem. In addition, it is predicted that limiting the time access of fructose to
the light period will increase adiposity and influence metabolic parameters.
2.2. Specific aims
The specific aims of this study are:
1. To test the hypothesis that timing (light vs. dark) of fructose consumption will
influence body weight, body fat, fat cell size, and metabolic parameters.
2. To test the hypothesis that timing (light vs. dark) of fructose consumption will
influence catecholaminergic activity in adipose tissue and brainstem.
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3. MATERIALS AND METHODS
3.1. Animals
C57BL/6 male mice with initial body weights (BW) of 22-24 g (Harlan Inc., Indianapolis, IN),
were housed individually (22ºC) with 12 hr light (270 Lux) and 12 hr dark. Mice were given ad
libitum access to standard mouse chow (58% CHO, 30% PRO, 12% FAT) and timed access to
water or fructose (10% in tap water).
3.2. Animals and treatments:
C57BL/6 male mice were assigned randomly to groups: 1) Control: 24 hr water (n=10); 2)
Fructose Light (FL): 12 hr fructose during the light period and 12 hr water during the dark period
(n=11); and 3) Fructose Dark (FD): 12 hr fructose solution during the dark period and 12 hr
water during the light period (n=11). Total fluid intake, chow consumed, body weight, and body
fat was measured at weeks 2, 4 and 6. A glucose tolerance test was performed at week 8. Mice
were sacrificed by decapitation at week 9. Experimental protocols were approved by the Wright
State University Laboratory Animal Care and Use Committee.
3.3. Histology and cell Measurement of white adipose tissue
Epididymal adipose tissue was fixed in 4% paraformaldehyde. Paraffin embedded tissues were
sectioned (5 um) and stained with hematoxylin and eosin (H&E) (AML Laboratories Inc.,
Rosedale, MD). Tissues were examined using light microscopy and digital images were taken.
Images were analyzed using a computerized imaging system, MetaMorph® version 7.6
(Molecular Devices Inc., Sunnydale, CA). Images were saved as 24-bit TIF files for computer
processing. Specifically, four tissue sections from each animal were used for analysis with two
digital images made of each section. For each image, the number and area of the cells were
measured in a defined region. The tissue was manually checked so that broken cells or damaged
areas were removed from consideration.
10

3.4. Immunohistochemical staining for tyrosine hydroxylase (TH) in epididymal fat
To determine the level of tyrosine hydroxylase in fat tissue, fixed sections of epididymal fat were
deparaffinized with xylene and hydrated. Sections were incubated in Na citrate (0.01M), boiled
at 950C for 20 min, and cooled for one hour at room temperature. Sections were then washed
four times for 5 min each with 0.1 M. phosphate buffered saline (PBS) and washed with 0.5%
bovine serum albumin (BSA, Sigma Aldrich, St. Louis, MO) plus 0.4% Triton X-100 (Fisher
Scientific, Pittsburgh, PA) and 0.3% H2O2 (Sigma) for 15 min at room temperature to block
endogenous peroxidase . Tissue was then washed with PBS (7.5 pH) four times for 5 min and
finally washed with 0.5% BSA for 10 min. A hydrophobic pen was used to draw a circle around
the tissue and allowed to dry before adding the blocking solution (normal goat serum in buffer
1% BSA).

After incubating with primary TH antirabbit antibody (Pel-Freeze Biologicals,

Rogers, AR) [1:500] for 1 hr at room temperature, the tissue was refrigerated overnight.
After 24 hours incubation, the tissue was washed with 0.1M PBS (7.4 pH) four times for
5 min each and then washed with 0.5% BSA for 10 min. A secondary antibody (goat/antirabbit)
was added [1:500] to the tissue and incubated for two hours at room temperature. During this
two-hour incubation period, ABC solution (Vector Laboratories, Burlingame, CA) was prepared
at least 30 min prior to use. Again, the tissue was washed with 0.01M PBS (7.4 pH) four times
for 5 min each.
The next step involved tissue washing with 0.5% BSA + 0.4% Triton -X100 in 0.01M
PBS (7.4 pH) for 10 min. Following this, 1 ml of 0.01 M PBS + 2 µl of reagent A + 2 µl of
reagent B were combined and allowed to sit on ice for 30 min. This solution was then added to
the slides, which sat for 1 hour at room temperature. The tissue was washed with 50 mM buffer
A (8.505 g NaCl + 0.3405 g Midazol dissolved in 500 ml dH2O) two times for 5 min each,
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washed with diaminobenzidine (DAB) (Vector Laboratories, Burlingame, CA) solution (40 ml
buffer A + 10 mg tablet DAB 3 + 3, 3'-diaminobenzidine tetrahydrochloride + 200 µl of H2O2 +
10 µl of 30% H2O2 + 1 ml dH2O) and placed on a shaker for 10 min or until the tissue took on a
brown color. Slides were again rinsed with 0.01M PBS two times for 3 min each. Finally, the
slides were dipped in H&E for 5 sec and dehydrated by going through increasing concentrations
of ethanol (70%, 95%, and 100%) for 1 min each, ending in a 5 min xylene wash. Cover slips
were placed over the tissue using mounting media (Fisher Scientific, Pittsburgh, PA) and dried.
Slides were photographed at 20X magnification.
3.5. Immunohistochemistry of TH in brainstem
The method was the same for TH staining in brainstem. Frozen (-800 C) brainstem sections (25
um) from each group were processed for immunochemistry. The brainstem sections were rinsed
in 0.01 M PBS (7.4 pH) solution. Slides were placed on a tray and allowed to sit at room
temperature for one hour. This step was followed by washing with 0.01 M PBS (7.4 pH) two
times for 2 min each. The slides were next inserted into a container with 15% H2O2 ((2 µl of
H2O2 + 10 ml of 0.1 M PBS (7.4 pH)) and placed on a shaker for 15 min. After 15 min, the
tissue was washed with 0.01 M PBS (7.4 pH) three times for 5 min each .A hydrophobic pen was
used to draw a circle around the tissue and allowed to dry for few seconds before adding
the blocking solution ((10 ml 0.01 M PBS (7.4 pH) + 150 ul of normal goat serum + 10 µl of
0.4% Trion-100)). Primary antibody (Pel-Freeze Biologicals, Rogers, AR) rabbit/antirabbit
[1:1000] was added. The tissue then sat at room temperature for one hour followed by
refrigeration overnight.
The next day slides were again washed with 0.1M PBS (7.4 pH) two times for 5 min
each. Again, the tissues on slides were circled with a hydrophobic pen. The secondary antibody,
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goat/antirabbit (Vector Laboratories, Burlingame, CA), was added [1:1000] to the tissue and
incubated for one hour. While the tissue was incubating, an avidin-biotin peroxidase complex
((2 µl of reagent A + 2 µl of reagent B + 1 ml of 0.01 M PBS (7.4 pH)) was prepared at least 30
min prior to use and kept on ice. After incubation, tissues were washed with buffer B. This step
was followed by washing the tissue with 50 mM of buffer A two times for 5 min each and lastly
washed with DAB solution ((20 ml buffer B + 10 mg tablet DAB + 200 ul of H2O2 +10 µl of
30% H2O2 + 1 ml dH2O)). Containers with the slides were then set on the shaker with the DAB
solution for 10 min (or until the tissue turned black).
Tissues were rinsed to remove the DAB solution with 0.01 M PBS two times for 5 min
each. Slides were then dried for 30 min to 1 hour and dehydrated using increasing percentages of
ethanol 70%, 95%, 100% solutions for 1 min each. Slides were then placed in xylene for 5 min.
Cover slips were placed on the slide with mounting media (Fisher Scientific, Pittsburgh, PA) and
dried. Slides were photographed at 20X magnification. The TH was measured quantitatively by
comparing one slide per animal from each group.
3.5. High-performance liquid chromatography coupled with electrochemical detection
(HPLC-ED)
To determine the concentrations of norepinephrine (NE), epinephrine (EPI), and dopamine
(DA) in fat, 60 mg of epididymal tissue was removed from the -800 C freezer and placed in a
tube with 500 µl of cold 0.4 N perchloric acid and homogenized using a sonicator three time at
20 sec each. Samples were then centrifuged at 4⁰ C and 13,000 rpm for 10 min. Supernatant
(400 µl) was transferred to a 2 ml tube. To this tube, 50 mg of alumina (aluminium oxide)
(Sigma-Aldrich, St. Louis, MO) and 45 µl of dihydroxybenzylamine hydrobromide (DHBA - 50
ng/ml) were added. DHBA was used as the internal standard and 0.5 M Tris buffer (9.0 pH) was
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added to adjust the pH to 8.5. The mixture was vortexed for 30 sec and centrifuged for 1 min at
1000 rpm so that the alumina precipitated to the bottom.
After removing the buffer, the remaining alumina was washed with 1 ml of dH2O,
vortexed, and centrifuged three times. Elution was performed by adding 200 µl of 0.1 N
perchloric acid (0.1 N perchloric acid with 1.0 mM Na metabisulfate). Following a 30 sec vortex
and spin for 1 min, the acid was removed. The remaining homogenates were centrifuged at
13,000 rpm at 40C for 10 min. Two aliquots (20 µl) of supernatant were injected into the HPLC.
Chromatographic separation was conducted using an ESA 80 × 4.6 mm column packed with 3
μm of C18 resin and a LC-4B amperometric detector (Bioanalytical Systems Inc. BASi)
optimized to 0.75 V. The mobile phase consisted of a stock of 8.204 sodium citrate, 0.0584 g
EDTA disodium salt (C10H14O8Na2N2), 11.516 g citric acid, and 110 ml ProClin® solution. For
running urinary catecholamines, 500 ml of stock solution + 0.12884 g 1-octanesulfonic acid
(C8H17O3SNa: sodium ethyl hexyl sulfonate) and 35 ml MeOH (methanol) was made. The pH
was adjusted to 8.5 using Tris buffer (9.0 pH). The HPLC flow rate was set at 0.6 ml/min. A
standard, containing a known amount of the monoamines - norepinephrine (NE), epinephrine
(EPI), dihydroxybenzylamine hydrobromide (DHBA), and dopamine (DA), was injected into the
chromatography system. The concentrations of monoamines in the samples were determined by
comparing the peak amplitude from the samples to that obtained from known standard
concentrations. The concentrations of NE, EPI, and DA were determined and expressed as pg/ng
of tissue.
3.6. Statistical analysis
Male C57BL mice were given standard chow and assigned to one of three groups: Control
(n=10, water 24h); FL (n=11, 10% fructose solution during 12h light period); and FD (n=10,

14

10% fructose solution during 12h dark period).

Statistical analysis was performed using

GraphPad Prism® (v. 5.01) (GraphPad Software, La Jolla, CA) and STATISTICA® software
(v.10) (StatSoft, Tulsa, OK). All data are expressed as mean ± SEM. Statistical significance was

assessed by one-way, two-way, or repeated-measures analysis of variance (ANOVA) followed
by Tukey’s HSD post hoc test. The significance level was set at two-tailed p<0.05.
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4. RESULTS
4.1. Metabolic parameters
4.1.1 Change in body weight: BW increased significantly for FL group over the 6 wk time
course (Fig 2).There was a significant difference in BW (p<0.05) observed for FL as compared
to FD.
4.1.2 Change in body fat: There was a significant increase in BF in FL group (Fig 2) (2.6 and 1.5
fold higher than Control and FD, respectively). FL animals had significantly more body fat
(FL>FD>C, p<0.05).
4.1.3 Adipocyte size: Fructose consumption induced a change in adipose cell size (Group effect,
p<0.03) (Fig 3). Adipocytes were significantly larger in the FL group when compared to Control
(p<0.05).
4.1.5. Plasma insulin: At the experiment’s 8-week termination, insulin was measured in nonfasted mice in the morning (Figure 4). Mice fed fructose during the light period (FL) had
significantly higher insulin levels compared to mice fed fructose during the dark (FD, p<0.05).
There was no difference as compared to controls (Fig 4).
4.1.6. Plasma leptin: There was a significant elevation in plasma leptin for mice fed fructose in
the light period (FL) compared to those fed fructose during the dark period and controls. (Fig.4,
p<0.05) .
4.1.7 Glucose tolerance test GTT: There was no significant difference among treatment groups
for GTT data (FL: 192 ± 7.4 AUC/min, FD: 187 ± 7.5 AUC/min, Control: 204 ± 8.6 AUC/min)
(Table 1).
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4.1.8 Plasma glucose: There was no significant difference in plasma glucose level among the
groups, although there was significant increasing plasma levels of insulin and leptin hormones
(FL: 139 ± 22.0 mg/dL, FD: 154.4 ± 21 mg/dL, Control: 157 ± 23.6 mg/dL) (Table 1).
4.1.9 Plasma triglyceride and cholesterol levels: After 8 weeks, cholesterol and triglyceride
levels of the fructose fed mice and the control group were measured using specific colorimetric
assays. There was no significant difference among groups for these variables: cholesterol (FL
92.6 ± 8.0 mg/dL, FD: 90 ± 5.5 mg/dL, Control: 82.7 ± 6.3 mg/dL); triglycerides (FL: 89 ± 12.0
mg/dL, FD: 89 ± 8.0 mg/dL, Control: 82.7 ± 6.3 mg/dL) (Table 1).
4.2. Measurement of Catecholamine Activity
4.2.1 Immunohistochemistry of TH in white adipose tissue: Immunohistochemistry was
conducted and followed by HPLC analyses, which quantitatively measured the catecholamine
level. Immunostaining of TH for FL on adipose tissue and brainstem was used since it was
difficult to measure catecholaminergic activity accurately using TH staining. Electrochemical
methods for direct measurement of NE and EPI levels (Fig 6) were employed.
4.2.2 Catecholamine level in white adipose tissue: To investigate the effect of fructose limited
access time on catecholamine activity, HPLC method was performed to measure NE and EPI
quantitatively in epididymal adipose tissue. There was a trend for higher levels of catecholamine
in the FL group, which indicated that the time of response is critical (Fig 8).
4.2.3 Immunohistochemistry of TH in brainstem: There was robust staining for TH in the
brainstem, specifically in the locus coeruleus (LC). Staining was qualitatively greater in the FL
group (Fig 9).
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Table 1. Results of the glucose tolerance test (GTT) and plasma levels of glucose, adiponectin,
triglycerides and cholesterol (after 8 weeks)
Group

GTT
(AUC/min)

Glucose
(mg/dL)

Adiponectin
(µg/dL)

Triglycerides
(mg/dL)

Cholesterol
(mg/dL)

Control

204±8.6

157.1±23.6

12. ±0 1.8

77± 9.3

82.7± 6.3

F12L

192± 7.4

139 ±22.0

10.7± 2.4

89± 12.0

92.6± 8.0

F12D

187 ±7.5

154.5± 21.0

11.5± 2.1

92.6± 8.0

90.2± 5.5

Data are means ± SEM. There were no significant differences among the groups for any of the
variables at 8 weeks. Control (n=10, water 24h); FL (n=11, 10% fructose solution during 12h
light period); and FD (n=10, 10% fructose solution during 12h dark period).
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Figure 2. Data are means ± SEM. Changes in (A) bodyweight and (B) body fat at 2 ( ) and 6
weeks ( ) after the initiation of dietary treatment. Control (n=10, water 24h); FL (n=11, 10%
fructose solution during 12h light period); and FD (n=10, 10% fructose solution during 12h dark
period).Two-way repeated measures ANOVA showed a significant effect of time on bodyweight
(F1,29 = 47.2; p< 0.0001). Two-way repeated measures ANOVA for body fat showed significant
effects of Group (F2,29 = 3.85; p < 0.03), Time [(F1,29 = 60.6; p < 0.001) and a Group × Time
interaction (F2,29 = 5.04; p< 0.013). **p< 0.01 compared with 2 weeks; †p< 0.01 compared with
control values at 6 weeks; ‡ p< 0.05 compared with fructose dark group at 6 weeks.
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Figure 3. Procedure for MetaMorph® for white adipose tissue (WAT). Images of WAT were
processed to measure the adipocyte size on the mice in the three groups Control: water only; FL:
water during dark period and fructose during light period; FD: water during light period and
fructose during dark period. A and D are original images of WAT. B, E, C, and F are images of
result of adipocyte size in certain region was created (800pixelx800 pixel) , For each image, the
number and area of the cells were measured in a defined region.
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Figure 4. Data are means ± SEM. Cell size in white epididymal fat. Fixed, hematoxylin and
eosin stained tissue was examined using light microscopy and image analysis. Control (n=10,
water 24h); FL (n=11, 10% fructose solution during 12h light period); and FD (n=10, 10%
fructose solution during 12h dark period). Analysis using ANOVA showed a group effect (F2,18 =
3.80; p< 0.042). *p< 0.05 compared with Control.
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Figure 5. Data are means ± SEM. Insulin and leptin levels in the Control (n=10, water 24h); FL
(n=11, 10% fructose solution during 12h light period); and FD (n=10, 10% fructose solution
during 12h dark period). Analysis using ANOVA showed a significant Group effect for insulin
(F2,17 = 5.62; p< 0.015) and leptin (F2,18 =3.85; p< 0.042). *p< 0.05 compared with the FD group.
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Figure 6. Immunostaining of tyrosine hydroxylase (TH) in the white adipose tissue. TH staining
showed localization of the brown reaction product in the adipose cells. A) Control: Water only;
(B) FL: Water during dark period and fructose during light period; and (C) FD: Water during
light period and fructose during dark period
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Figure 7. Standards chart for catecholamine measuring (1nA). A standard, containing a known
amount of the monoamines - norepinephrine (NE), epinephrine (EPI), dihydroxybenzylamine
hydrobromide (DHBA), and dopamine (DA), was injected into the chromatography system. The
concentrations of monoamines in the samples were determined by comparing the peak amplitude
from the samples to that obtained from known standard concentrations. The concentrations of
NE, EPI, and DA were determined and expressed as pg/ng of tissue.
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Figure 8. Data are means ± SEM. Plasma hormone levels (ng/mL). One-way ANOVA showed
that there were no significant differences among the groups for catecholamine levels of NE and
EPI. Control (n=10, water 24h); FL (n=11, 10% fructose solution during 12h light period); and
FD (n=10, 10% fructose solution during 12h dark period).
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Figure 9. Immunostaining of tyrosine hydroxylase (TH) on brainstem of C57BL/6 mice in the
locus coeruleus (LC). After 8 weeks of 10 % fructose treatment, staining was qualitatively
greater in the FL group compared to FD and Control groups. Control (n=10, water 24h); FL
(n=11, 10% fructose solution during 12h light period); and FD (n=10, 10% fructose solution
during 12h dark period).
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5. DISCUSSION
This study tested the hypothesis that limited time access to fructose causes activation of adipose
and brain catecholaminergic activity as well as metabolic pathologies in mice. The results show
that consumption of fructose during the light or sleep period in male C57BL/6 mice produced
altered metabolic and endocrine responses (Morris et al., 2011). This was seen as enhanced
insulin and leptin levels with increased adiposity and fat cell size. Immunohistochemistry
showed staining for TH in adipose tissue and brainstem. Qualitative examination of the stain
suggested increased catecholaminergic activity in both tissues. Electrochemical measurement of
catecholamines, NE and EPI, in adipose tissue showed no significant changes. Our results
document the importance of the timing of nutrient intake in causing metabolic disease. Questions
remain as to the role of catecholamines in mediating the changes.
Epidemiological and experimental studies in humans and animals confirm that high
fructose consumption causes metabolic and autonomic disorders including insulin resistance,
obesity, autonomic dysfunction, and lipid and renal abnormalities (Bray, Nielsen, & Popkin,
2004; Katovich et al., 2001; Dai & McNeill, 1995; Farah et al., 2006; Hsieh, 2005). Autonomic
dysfunction plays a major role in the etiology of such syndromes. The clusters of metabolic and
hemodynamic alterations are characterized by an increase in sympathetic drive (Grassi &
Seravalle, 2006; Landsberg, 2001; De, Senador, Mostarda, Irigoyen, & Morris, 2012). There is
much information on the cardiovascular and metabolic effects of a fructose supplemented diet in
animal models. Fructose fed rats and mice show a moderate hypertension and glucose
intolerance associated with high levels of plasma cholesterol, and TG (Lindmark, Wiklund,
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Bjerle, & Eriksson, 2003; Kamide et al., 2002; Dai & McNeill, 1995; Farah et al., 2006; Hsieh,
2005). There is evidence for a role of the sympathetic nervous and renin angiotensin systems
(RAS) in fructose- induced cardiovascular and renal changes (Cunha et al., 2007; Van Gaal,
Mertens, & De Block, 2006). In a study done with fructose feeding in rats, fructose induced
sympathetic activity and increased urinary catecholamine excretion (Kamide et al., 2002). An
association between cardiovascular, autonomic and metabolic dysfunction in humans and
animals has been demonstrated (Van Gaal et al., 2006; Hellstrom, 2007).
As an index of catecholaminergic activity in adipose tissue, immunostaining for TH and
electrochemistry for measurement of NE and EPI levels was utilized. Staining showed
localization of the brown reaction product in the adipose cells. Given the structure of adipocytes
which contain a large central vacuole (Fig 1), it was difficult to quantitatively compare staining
in the tissues. This difficulty was also seen in the quantitative measurement of TH in vascular
tissue. TH fibers were seen around vessels and in close association with adipocytes, but it was
not possible to verify the level of change (Murano, Barbatelli, Giordano, & Cinti, 2009). In
epididymal WAT of Siberian hamsters, it was also difficult to detect TH due to the close packing
of the adipocytes (Shi, Song, Giordano, Cinti, & Bartness, 2005). However, in the present study
it appeared that WAT staining was heavier in the FL group which had morefat and greater
metabolic damage. In a quantitative assessment of TH activity in epididymal adipose tissue of
fructose-fed rats, there were no significant differences between groups (Baret et al., 2002). It
was easier to detect nerve fibers in fat tissue from animals in a fasted state since cell size was
smaller and parenchymal area was larger (Slavin & Ballard, 1978). Because it was difficult to
measure catecholaminergic activity accurately using TH staining, electrochemical methods for
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direct measurement of NE and EPI levels were used (Lucot, Jackson, Bernatova, & Morris,
2005).
For the HPLC/electrochemical method, fat tissue is extracted with alumina, amines are
separated by HPLC, and NE and EPI are measured by electrochemistry (Lucot, Crampton,
Matson, & Gamache, 1989). This method is useful for measuring catecholamine levels
accurately in tissues, urine, and plasma. NE levels in WAT were 0.08 pg/ng in FD vs. 16 pg/ng
in FL. EPI levels were 0.14 pg/ng in FD vs. 9.45 pg/ng in FL (Fig. 8). The levels appear higher
in the FL group as hypothesized, but because of the large variance, changes were nonsignificant.
There are other reports of catecholamines in mice and rats WAT . Short term feeding (6 days) of
fructose showed no change in NE levels in fat (Young, Weiss, & Boufath, 2004). Animals fed
fructose for 6 weeks showed no significant change in SNS activation in epididymal (Baret et al.,
2002). Most experiments using fructose provide 24 hr accesses. The design of the present study
is unique since it compares the effect of limited light/dark consumption. Indeed, there was a
trend for increase both for TH and catecholamine content.
As a complement to the adipose measurements, TH staining in the brainstem source for
sympathetic innervation of adipose tissue was examined. There was robust staining for TH in the
brainstem, specifically in the locus coeruleus (LC). Staining was qualitatively greater in the FL
group (Fig. 10). Similar results were seen when fructose was given in the food (Farah, Joaquim,
& Morris, 2006; Farah et al., 2006). Fructose fed mice showed marked increases in brainstem
TH mRNA expression, indicating central actions of the diet. CNS activation may play a role in
the cardiovascular and metabolic changes induced by fructose.
With regard to metabolic changes resulting from fructose consumption, body fat, fat cell
size, and plasma levels of insulin and leptin were significantly increased. The changes were
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specific for the FL group, verifying the important influence of timing (light/dark).

In a study

performed in people who were fed three meals at different times over 24 hours (morning,
afternoon, night), results showed that the group eating at night had higher cholesterol levels than
the morning and afternoon groups although these groups ate more food (Morikawa et al., 2007).
High levels of TG were seen in shift workers, indicating that alteration of activity patterns is a
risk factor for coronary disease (Knutsson, Akerstedt, & Jonsson, 1988). Moreover, individuals
who worked at night showed higher risk for diabetes. Glycated hemoglobin was higher in night
workers compared to those working on a fixed day time schedule (Morikawa et al., 2005). These
studies established that alterations in sleeping or eating times are associated with risk factors
related to type 2 diabetes and heart disease. Along with these results, studies also show increases
in body weight in shift workers (obesity) (van Amelsvoort, Schouten, & Kok, 1999).
Experimentally, increases in blood pressure and plasma insulin and glucose were also seen in
individuals when circadian misalignment was induced, even acutely (Scheer et al., 2009).
Similarly, in animals, such a misalignment (light-dark cycle reversed) influenced the induction of
heart failure (Penev, Kolker, Zee, & Turek, 1998). Interestingly, heart attack and strokes were
found to occur more often during the early waking hours in humans (Muller, 1999; Elliott, 1998).
In mice exposed to chronic stress for 7 days, there were circadian patterns in the blood pressure
responses, higher levels in the light vs. dark (Bernatova, Key, Lucot, & Morris, 2002). The
experiments in the present study were designed to test the hypothesis that limited time access to
fructose causes activation of adipose and brain catecholamine activity as well as metabolic
pathologies.
Unlike glucose, fructose metabolism is not regulated by the energy state. After fructose
ingestion, its metabolism occurs independently of insulin because of the limitation of fructose
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uptake by the pancreas that lacks GLUT5 fructose transporters (Curry, 1989). In the liver,
fructose is rapidly phosphorylated by fructokinase and further converted to glyceraldehyde,
dihydroxyacetone phosphate, and glyceraldehyde 3-phosphate, intermediates in the glycolytic
pathway. These intermediates are metabolized to generate TG through the lipogenic process. The
speed of the metabolism is due mainly to the high affinity of fructokinase for fructose and the
phosphorylation which occurs independent of insulin. Therefore, fructose consumption has been
suggested to increase hepatic TG which can be packed into very-low density lipoproteins by the
liver and reduce TG clearance by adipose tissue. Although several studies linked fructose intake
with elevation in TG and cholesterol (Dai & McNeill, 1995; Hsieh, 2005), in the present study
there were no significant differences in TG or cholesterol among the treatment groups.
Most studies provide continuous access to fructose. The current study is unique since the
access of fructose was coupled to a limited daily period (12 hr light vs. dark) demonstrating that
there were significant differences among treatment groups depending on whether the sugar was
given during the light or dark period. The FL group showed significant increases in adiposity and
elevation in leptin and insulin levels. This occurred without differences in caloric intake among
the groups. These results establish additional experimental evidence that the time of intake is
critical to metabolism and the consequent pathologies. For example, when people are required to
work at night, they demonstrate elevated TG, lower HDL cholesterol, and weight gain (Esquirol
et al., 2009). People who work at night also have health implications in endocrine responses
(Holmback et al., 2003). Alterations in the pattern of metabolic hormone secretion as well as
increased body weight were confirmed in humans with nighttime snacking syndrome even
though total food intake was not different from controls (Goel et al., 2009; Colles et al., 2007).
Obesity and lack of blood glucose rhythms was noted in rats fed only during light time and
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exposed to constant slow movement (Salgado-Delgado, Angeles-Castellanos, Saderi, Buijs, &
Escobar, 2010). In the present study, fructose fed mice had an increase in fat cell size and body
fat. There were metabolic changes, but no decrease in activity. Increased epididymal fat and cell
size were noted in rats fed fructose (Furuhashi et al., 2004).
The current data showed significant differences in metabolic response in mice fed
fructose during the 12 hr light period. FL group had the highest levels of insulin and leptin
plasma with enhanced adiposity. Leptin is mainly produced by adipose tissue. This hormone
plays an important role in regulation of energy status by binding to specific receptors in the
hypothalamus causing decreased food intake and increased energy expenditure (Havel, 2005).
This organ is affected by alteration in circadian rhythms like other vital organs such as liver,
heart and kidney (Damiola et al., 2000; Zvonic et al., 2006).

Additionally, leptin displays a

diurnal pattern (Ahren, 2000; Teff et al., 2004) with other adipokines that are released from
adipose tissue (Gavrila et al., 2003). Circulating leptin level is directly correlated to adiposity
(Maffei et al., 1995). In addition, insulin and leptin have synergistic effects. Insulin increases
leptin gene expression and has a role in the diurnal pattern of leptin secretion (Saad et al., 1998;
Havel, 2002).
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6. CONCLUSION

The present study demonstrated that limited access time to a 10% fructose solution in mice
increased adiposity and produced diabetic like symptoms. There was a trend for SNS activation
as documented with TH staining (WAT and brainstem) and catecholamine levels in adipose
tissue. The changes were specific for the FL group and were dissociated from caloric intake.
Changes occurred when mice were given the sugary liquid during the light (inactive) period as
compared to dark phase consumption. Hormonal effects included increases in leptin and insulin
without changes in glucose or glucose tolerance. In conclusion, the results of the present study
document that restricting fructose access to the light inactive period produced pathological
effects as related to body fat, adipocyte size, and metabolic hormones with a trend toward SNS
changes. These data may have clinical implications, since the timing of intake could be important
in the control of adiposity and the development of metabolic syndrome.
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